Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

By C. Stettler, Simon Wandel, Sabin Allemann, A. Kastrati, M. Morice, A. Schömig, M. Pfisterer, Gregg Stone, M. Leon, J. S. de Lezo and 19 more. The Lancet, 2007

1,519 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/d5eed305c8240de0df8c5a6bc293e12903a17135

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. A. Ades
2. N. Welton
3. S. Dias
4. A. Sutton
5. Georgia Salanti
6. Ian R. White
7. Gerta Rücker
8. A. Chaimani

Citations in the corpus

• NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials (2011, methodology): “These models can be fitted if there is data reported at multiple follow-up times within the same study.(42,43) An alternative is to fit a”
• Coronary stents: current status. (2010, neutral): “(22), reported similar risk of death for patients treated with SES, PES, r BMS; the risk of MI, although comparable between PES nd BMS (p 0.”
• Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. (2011, background): “[32] Stettler C, Wandel S, Allemann S, et al.”
• The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare Metal and Drug-Eluting Stents (2011, neutral): “Unstable angina pectoris/AMI 47 (24) 59 (28) Lesion location Left main coronary artery 4 (2) 6 (3) Left anterior descending artery 73 (37) 87 (42) Left circumflex artery 45 (23) 51 (24)”
• Guidelines on myocardial revascularization. (2010, background): “I A [45,46,55,215]”